Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...

One day after a subcutaneous injection into the left thigh, she developed a mildly pruritic eruption on the right thigh, at the site of a previous injection. Etanercept (Enbrel ®) is an ...

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, ...

ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's diseaseONAPGO is a wearable subcutaneous infusion devi ...

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

The Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn disease in adults.

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...

A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...

Paradigm Biopharmaceuticals continues to edge closer towards starting the pivotal phase III trial for its knee osteoarthritis ...

This study will evaluate HCW9302 in patients with moderate to severe alopecia areata. MIRAMAR, Fla., Feb. 03, 2025 (GLOBE ...

Methods: In the present study, we investigated the toxicokinetics of FGF-21 delivered via subcutaneous injection in vivo ... the administration site, lymph nodes related to administration, bone marrow ...